Cellectar reverse stock split

CLRB Cellectar Biosciences, Inc. — Stock Price and ...

Cellectar Announces 1-for-10 Reverse Stock Split ... Jul 13, 2018 · On July 9, 2018, Cellectar’s Board of Directors approved the implementation of the reverse stock split and determined the appropriate reverse stock split to be a ratio of 1-for-10, subject to stockholder approval. Shares of Cellectar’s common stock will trade on a … CLRB Split History Cellectar Biosciences (CLRB) has 2 splits in our CLRB split history database. The first split for CLRB took place on March 07, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of CLRB owned pre-split, the shareholder now owned 1 share. Cellectar Announces 1-for-10 Reverse Stock Split Nasdaq:CLRB

CLRB Cellectar Biosciences, Inc. Stock Quote

Stock splits are used by Cellectar Biosciences, Inc. to keep share prices within reasonable If the share price gets too low, companies can do reverse splits. On March 4, 2016 at 5:00 p.m. Eastern Standard Time, the Company effected a reverse stock split at a ratio of 1-  CLRB Cellectar Biosciences, Inc. daily Stock Chart Jul-13-18 04:05PM, Cellectar Announces 1-for-10 Reverse Stock Split GlobeNewswire. Jul-09-18 08: 00AM  Aug 15, 2014 Cellectar Biosciences, a Madison, WI-based startup developing a 1-for-20 reverse stock split to boost its stock price—and its chances of  Cellectar Biosciences (NASDAQ:CLRB) will execute a 1:10 reverse split of its common stock effective after the close on Monday, July 16. Post-split trading will   Cellectar Announces 1-for-10 Reverse Stock Split ... Jul 13, 2018 · On July 9, 2018, Cellectar’s Board of Directors approved the implementation of the reverse stock split and determined the appropriate reverse stock split to be a ratio of 1-for-10, subject to stockholder approval. Shares of Cellectar’s common stock will trade on a …

The term reverse stock split is not one you will hear very often in the financial media, but it does creep up every once in a while when a company’s stock price is in trouble. To understand what a reverse stock split is, however, you first need to understand what a stock split is. Stock Splits

CLRB Cellectar Biosciences, Inc. Stock Quote Cellectar stock surges 15% premarket after FDA fast tracks treatment for rare childhood cancer MarketWatch: Cellectar Announces 1-for-10 Reverse Stock Split GlobeNewswire: Cellectar Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of Reverse Stock Splits Are Usually Good for Investors ... - CNBC Mar 22, 2011 · According to a new report by Cleve Rueckert, Birinyi Associates senior equity strategist, there have been 14 stocks in the S&P 500 since 2000 that have undergone a … Today's Research Reports on Trending Tickers: Onconova ...

On March 4, 2016 at 5:00 p.m. Eastern Standard Time, the Company effected a reverse stock split at a ratio of 1- 

Jul 16, 2018 · Cellectar Biosciences, Inc. (NASDAQ: CLRB) disclosed a 1-for-10 reverse stock split. Cellectar Biosciences shares rose 3.06 percent to close at $0.72 on Friday. Cellectar Biosciences, Inc. 10-Q Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒. Number of shares outstanding of the issuer’s common stock as of the latest practicable date: 5,368,235 shares of common stock, $0.00001 par value per share, as of November 7, …

Reverse Stock Split Definition - investopedia.com

Mar 22, 2011 · According to a new report by Cleve Rueckert, Birinyi Associates senior equity strategist, there have been 14 stocks in the S&P 500 since 2000 that have undergone a … Today's Research Reports on Trending Tickers: Onconova ... Sep 27, 2018 · Onconova announced a one-for-fifteen reverse stock split of its common stock, effective September 25, 2018. Shares of Cellectar Biosciences have gained roughly 20.5 percent in … 6 Stocks To Watch For July 16, 2018 | Benzinga Jul 16, 2018 · Cellectar Biosciences, Inc. (NASDAQ: CLRB) disclosed a 1-for-10 reverse stock split. Cellectar Biosciences shares rose 3.06 percent to close at $0.72 on Friday.

Cellectar drug data possible in 2017 Oct 31, 2016 · Under threat of being de-listed by the Nasdaq market after its stock had been trading for less than $1 in the past few months, Cellectar in March announced a …